AJP - Endo Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (September 9, 2008). doi:10.1152/ajpendo.90444.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/6/E1462    most recent
90444.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Gaetano, A.
Right arrow Articles by Porksen, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Gaetano, A.
Right arrow Articles by Porksen, N.
Submitted on May 16, 2008
Revised on July 31, 2008
Accepted on August 24, 2008

Mathematical Models of Diabetes Progression

Andrea De Gaetano1*, Thomas Hardy2, Benoit Beck3, Eyas Abu-Raddad2, Pasquale Palumbo1, Juliana Bue-Valleskey2, and Niels Porksen4

1 Consiglio Nazionale delle Ricerche
2 Eli Lilly and Company
3 Axiosis Sprl
4 Illy Lilly

* To whom correspondence should be addressed. E-mail: andrea.degaetano{at}gmx.net.

Few attempts have been made to model mathematically the progression of Type 2 diabetes. A realistic representation of the long-term physiologic adaptation to developing insulin resistance is necessary for effectively designing clinical trials and evaluating diabetes prevention or disease modification therapies. Writing a good model for diabetes progression is difficult, because the long time-span of the disease makes experimental verification of modeling hypotheses extremely awkward. In this context, it is of primary importance that the assumptions underlying the model equations properly reflect established physiology and that the mathematical formulation of the model give rise only to physically plausible behavior of the solutions. In the present work, a model of the pancreatic islet compensation is formulated, its physiological assumptions are presented, some fundamental qualitative characteristics of its solutions are established, the numerical values assigned to its parameters are extensively discussed (also with reference to available cross-sectional epidemiologic data), and its performance over the span of a lifetime is simulated under various conditions including worsening insulin resistance and primary replication defects. The differences with respect to two previously proposed models of diabetes progression are highlighted, and the model is therefore proposed as a realistic, robust description of the evolution of the compensation of the glucose-insulin system in healthy and diabetic individuals. Model simulations can be run from the Authors' webpage.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.